机构地区:[1]中山大学肿瘤防治中心实验研究部-华南肿瘤国家重点实验室,广州510060 [2]中山大学附属第一医院病理科 [3]广东省人民医院胃肠外科
出 处:《中华医学杂志》2007年第1期11-15,共5页National Medical Journal of China
基 金:国家自然科学基金(30300401);广尔省自然科学基金(04009327)
摘 要:目的探讨染色体与微卫星稳定型(MACS 型)结直肠癌(CRC)的染色体变异特征及其临床病理学意义。方法分别应用流式细胞学、微卫星不稳定性分析和免疫组织化学方法对156例 CRC 患者组织的 DNA 倍性、微卫星不稳定性和 DNA 错配修复蛋白(hMSH_2和 hMLH_1)表达进行了检测,筛选并确证 MACS 型 CRC;进一步应用比较基因组杂交(CGH)方法,检测 MACS 型 CRC 的染色体变异情况,结合患者的临床病理学资料,分析其相关性。结果在156例 CRC 患者中,有41例(26%)既是二倍体/近二倍体 DNA 含量的肿瘤,又呈现稳定的 DNA 微卫星序列,且均呈 hMSH_1和bMSH_2蛋白正常表达,确证为 MACS 型 CRC。CGH 检测结果显示,41例 MACS 型 CRC 患者染色体的总体平均变异(扩增和缺失)数目为9.6;染色体 DNA 扩增频率≥10%的位点依次出现于:20 q(68%)、13 q(56%)、7 q(49%)、13 p(39%)、20 p(37%)、8 q(30%)、1 q(22%)、11 q(15%)、16 q(12%)、2 p,4 q 和10 q(10%);染色体 DNA 缺失频率≥10%的位点依次为:18 q(63%)、8 p(51%)、17 p(37%)、1 p(30%)、3 p(26%)、4 p、13 q 和14(15%)、21 q 和 Xp(10%);在 Dukes’C/D 期的CRC 中,分别有79%和82%的肿瘤出现染色体20 q 扩增和18 q 缺失,变异率明显高于 Dukes'A/B 期的 CRC(46%,P=0.038;21%,P=0.0009)。结论 MACS 型 CRC 的染色体变异频数接近于染色体不稳定(C1)型 CRC,但高于微卫星不稳定(MSI)型 CRC;染色体8 p 的高频缺失可能是 MACS 型CRC 不同于 CI 型和 MSI 型 CRC 相对独特的分子事件;染色体20 q 扩增和18 q 缺失是 MACS 型 CRC中最为频发的染色体变异,并与该型 CRC 的恶性临床表型密切相关,可能在其恶性进展中担当十分重要的作用。Objective To investigate the clinico-pathological significance and characteristics of chromosomal abnormalities in microsatellite and chromosome stable (AMCS) colorectal carcinoma (CRC). Methods Flow cytometry, microsatellite instability analysis and immunohistochemistry methods were used to examine the DNA ploidy, microsatellite instability and expression of mismatch repair proteins (hMSH2 and hMSH1 ) in 156 cases of CRCs, so as to select the MACS CRCs. Comparative genomic hybridization (CGH) method was subsequently performed to analyze the status of chromosomal abnormalities of MACS CRCs. The correlation between chromosomal changes of MACS CRC and patients clinico-pathological features was further evaluated. Results Of the 156 CRCs studied, fourty-one (26%) cases were observed both diploid/near diploid DNA content and stable microsatellite sequence and all these CRCs showed normal expression of hMSH2 and hMSH1 protein, and thus, defined as MACS CRC. Our CGH results showed that the overall mean numbers of chromosomal abnormality of 41 MACS CRCs was 9.6. The chromosomal arms with DNA amplification (frequency ≥ 10%) were 20 q(68%), 13 q(56%), 7 q(49%), 13 p(39% ), 20 p (37%), 8 q(30%), 1 q(22%), 11 q(15%), 16 q(12%) and 2 p, 4 q, 10 q(10%). The chromosomal arms with DNA deletion (frequency≥10% ) were 18 q(63% ) , 8 p(51% ) , 17 p(37% ) , 1 p(30%), 3 p (26%), 4p, 13 q, 14(15%) and 21 q, Xp(10%). In addition, there was 79% and 82% MACS CRCs in Dukes'C/D stages observed amplification of 20 q and deletion of 18 q, respectively, the frequency was significantly higher that that in Dukes'A/B stages (46% , P = 0.038 and 21% ,P = 0. 0009 ). Conehtsions The overall number of chromosomal abnormalities in MACS CRCs is similar to that of chromosomal instable (CI) CRCs, but is higher than that of microsatellite instable (MSI) CRCs. The frequent deletion of 8 p in MACS CRCs might be a special molecular event that i
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...